
Prince Akwasi Mensah
Examiner (ID: 16550, Phone: (571)270-7183 , Office: P/2474 )
| Most Active Art Unit | 2474 |
| Art Unit(s) | 2416, 2474 |
| Total Applications | 590 |
| Issued Applications | 431 |
| Pending Applications | 63 |
| Abandoned Applications | 119 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3769710
[patent_doc_number] => 05773440
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/880473
[patent_app_country] => US
[patent_app_date] => 1997-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5601
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773440.pdf
[firstpage_image] =>[orig_patent_app_number] => 880473
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/880473 | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives | Jun 22, 1997 | Issued |
Array
(
[id] => 4013805
[patent_doc_number] => 05880098
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-09
[patent_title] => 'Therapeutic treatment'
[patent_app_type] => 1
[patent_app_number] => 8/878557
[patent_app_country] => US
[patent_app_date] => 1997-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 4718
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/880/05880098.pdf
[firstpage_image] =>[orig_patent_app_number] => 878557
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/878557 | Therapeutic treatment | Jun 18, 1997 | Issued |
Array
(
[id] => 4217885
[patent_doc_number] => 06087386
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Composition of enalapril and losartan'
[patent_app_type] => 1
[patent_app_number] => 8/877742
[patent_app_country] => US
[patent_app_date] => 1997-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8188
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/087/06087386.pdf
[firstpage_image] =>[orig_patent_app_number] => 877742
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/877742 | Composition of enalapril and losartan | Jun 16, 1997 | Issued |
Array
(
[id] => 3934459
[patent_doc_number] => 05929095
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'Method of inhibiting secretory effects caused by Cholera'
[patent_app_type] => 1
[patent_app_number] => 8/877748
[patent_app_country] => US
[patent_app_date] => 1997-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 3701
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/929/05929095.pdf
[firstpage_image] =>[orig_patent_app_number] => 877748
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/877748 | Method of inhibiting secretory effects caused by Cholera | Jun 16, 1997 | Issued |
Array
(
[id] => 3877061
[patent_doc_number] => 05747485
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Substituted azetidiones as anti-inflammatory and antidegenerative agents'
[patent_app_type] => 1
[patent_app_number] => 8/848076
[patent_app_country] => US
[patent_app_date] => 1997-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22498
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747485.pdf
[firstpage_image] =>[orig_patent_app_number] => 848076
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/848076 | Substituted azetidiones as anti-inflammatory and antidegenerative agents | Jun 4, 1997 | Issued |
Array
(
[id] => 4199334
[patent_doc_number] => 06013670
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-11
[patent_title] => 'Use of alkanoyl L-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases'
[patent_app_type] => 1
[patent_app_number] => 8/868627
[patent_app_country] => US
[patent_app_date] => 1997-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1195
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/013/06013670.pdf
[firstpage_image] =>[orig_patent_app_number] => 868627
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/868627 | Use of alkanoyl L-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases | Jun 3, 1997 | Issued |
Array
(
[id] => 4143894
[patent_doc_number] => 06031001
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-29
[patent_title] => 'Use of prostaglandins'
[patent_app_type] => 1
[patent_app_number] => 8/809017
[patent_app_country] => US
[patent_app_date] => 1997-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1814
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/031/06031001.pdf
[firstpage_image] =>[orig_patent_app_number] => 809017
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/809017 | Use of prostaglandins | May 15, 1997 | Issued |
Array
(
[id] => 3993730
[patent_doc_number] => 05919757
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-06
[patent_title] => 'Aqueous pharmaceutical preparations of G-CSF with a long shelf life'
[patent_app_type] => 1
[patent_app_number] => 8/857172
[patent_app_country] => US
[patent_app_date] => 1997-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6958
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/919/05919757.pdf
[firstpage_image] =>[orig_patent_app_number] => 857172
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/857172 | Aqueous pharmaceutical preparations of G-CSF with a long shelf life | May 14, 1997 | Issued |
| 08/852266 | METHOD OF TREATING POLYCYSTIC KIDNEY DISEASE | May 5, 1997 | Abandoned |
Array
(
[id] => 3840465
[patent_doc_number] => 05744502
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-28
[patent_title] => 'Method for increasing the production of/in breeding and production animals in the poultry industry'
[patent_app_type] => 1
[patent_app_number] => 8/793803
[patent_app_country] => US
[patent_app_date] => 1997-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2197
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/744/05744502.pdf
[firstpage_image] =>[orig_patent_app_number] => 793803
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/793803 | Method for increasing the production of/in breeding and production animals in the poultry industry | Apr 29, 1997 | Issued |
Array
(
[id] => 4352563
[patent_doc_number] => 06291445
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Low dose budesonide formulations and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/846960
[patent_app_country] => US
[patent_app_date] => 1997-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1645
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291445.pdf
[firstpage_image] =>[orig_patent_app_number] => 846960
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/846960 | Low dose budesonide formulations and uses thereof | Apr 28, 1997 | Issued |
Array
(
[id] => 6894216
[patent_doc_number] => 20010016582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-23
[patent_title] => 'METHOD AND COMPOSITION FOR THE TREATMENT OF LIPID AND GLUCOSE METABOLISM DISORDERS'
[patent_app_type] => new
[patent_app_number] => 08/848538
[patent_app_country] => US
[patent_app_date] => 1997-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10066
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20010016582.pdf
[firstpage_image] =>[orig_patent_app_number] => 08848538
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/848538 | METHOD AND COMPOSITION FOR THE TREATMENT OF LIPID AND GLUCOSE METABOLISM DISORDERS | Apr 27, 1997 | Abandoned |
Array
(
[id] => 3815721
[patent_doc_number] => 05789443
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-04
[patent_title] => 'Method for treating flushing associated with menopause'
[patent_app_type] => 1
[patent_app_number] => 8/847468
[patent_app_country] => US
[patent_app_date] => 1997-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2259
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/789/05789443.pdf
[firstpage_image] =>[orig_patent_app_number] => 847468
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/847468 | Method for treating flushing associated with menopause | Apr 24, 1997 | Issued |
Array
(
[id] => 3992386
[patent_doc_number] => 05891867
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'Hormonal medicaments and their use for the correction of oestrogenic deficiencies'
[patent_app_type] => 1
[patent_app_number] => 8/817329
[patent_app_country] => US
[patent_app_date] => 1997-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3421
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/891/05891867.pdf
[firstpage_image] =>[orig_patent_app_number] => 817329
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/817329 | Hormonal medicaments and their use for the correction of oestrogenic deficiencies | Apr 23, 1997 | Issued |
Array
(
[id] => 3840213
[patent_doc_number] => 05744484
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-28
[patent_title] => 'Lubeluzole intravenous solutions'
[patent_app_type] => 1
[patent_app_number] => 8/817740
[patent_app_country] => US
[patent_app_date] => 1997-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2848
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/744/05744484.pdf
[firstpage_image] =>[orig_patent_app_number] => 817740
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/817740 | Lubeluzole intravenous solutions | Apr 22, 1997 | Issued |
Array
(
[id] => 3862493
[patent_doc_number] => 05795916
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-18
[patent_title] => 'Composition of external preparation'
[patent_app_type] => 1
[patent_app_number] => 8/776700
[patent_app_country] => US
[patent_app_date] => 1997-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3845
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/795/05795916.pdf
[firstpage_image] =>[orig_patent_app_number] => 776700
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/776700 | Composition of external preparation | Apr 20, 1997 | Issued |
Array
(
[id] => 3984228
[patent_doc_number] => 05861425
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'Indole-ethanamines'
[patent_app_type] => 1
[patent_app_number] => 8/845053
[patent_app_country] => US
[patent_app_date] => 1997-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29152
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 363
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/861/05861425.pdf
[firstpage_image] =>[orig_patent_app_number] => 845053
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/845053 | Indole-ethanamines | Apr 17, 1997 | Issued |
Array
(
[id] => 3808200
[patent_doc_number] => 05854248
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-29
[patent_title] => 'Nefazodone: use in migraine prophylaxis'
[patent_app_type] => 1
[patent_app_number] => 8/843671
[patent_app_country] => US
[patent_app_date] => 1997-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1511
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/854/05854248.pdf
[firstpage_image] =>[orig_patent_app_number] => 843671
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/843671 | Nefazodone: use in migraine prophylaxis | Apr 9, 1997 | Issued |
Array
(
[id] => 3793583
[patent_doc_number] => 05780479
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-14
[patent_title] => 'Use of opioid antagonists to treat impulse-control disorders'
[patent_app_type] => 1
[patent_app_number] => 8/835080
[patent_app_country] => US
[patent_app_date] => 1997-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4522
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/780/05780479.pdf
[firstpage_image] =>[orig_patent_app_number] => 835080
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/835080 | Use of opioid antagonists to treat impulse-control disorders | Apr 3, 1997 | Issued |
Array
(
[id] => 3882441
[patent_doc_number] => 05798338
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-25
[patent_title] => 'Solid dosage forms that contain clathrates of 17.alpha.-ethinyl estradiol'
[patent_app_type] => 1
[patent_app_number] => 8/765823
[patent_app_country] => US
[patent_app_date] => 1997-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1489
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/798/05798338.pdf
[firstpage_image] =>[orig_patent_app_number] => 765823
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/765823 | Solid dosage forms that contain clathrates of 17.alpha.-ethinyl estradiol | Apr 1, 1997 | Issued |